CITI/CALL/SIEMENS HEALTHINEERS/48/0.1/19.12.24 Stock

Warrant

DE000KH9FQP2

Delayed Deutsche Boerse AG 12:23:57 2024-06-18 pm EDT
0.69 EUR -2.82% Intraday chart for CITI/CALL/SIEMENS HEALTHINEERS/48/0.1/19.12.24
Current month-7.79%
1 month-5.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-18 0.69 -2.82%
24-06-17 0.71 -10.13%
24-06-14 0.79 -3.66%
24-06-13 0.82 -7.87%
24-06-12 0.89 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 18, 2024 at 12:23 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SIEMENS HEALTHINEERS AG
IssuerLogo Issuer Citi Citi
WKN KH9FQP
ISINDE000KH9FQP2
Date issued 2023-08-29
Strike 48
Maturity 2024-12-19 (184 Days)
Parity 10 : 1
Emission price 0.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.18
Lowest since issue 0.45

Company Profile

Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
Sector
-
More about the company

Ratings for Siemens Healthineers AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Siemens Healthineers AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
52.52 EUR
Average target price
60.47 EUR
Spread / Average Target
+15.13%
Consensus